Cover Image
市場調查報告書

骨礦物質診斷檢驗的全球市場:2015∼2019年

Global Bone and Mineral Diagnostic Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345488
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
骨礦物質診斷檢驗的全球市場:2015∼2019年 Global Bone and Mineral Diagnostic Testing Market 2015-2019
出版日期: 2015年11月18日 內容資訊: 英文 76 Pages
簡介

骨礦物質代謝疾病,是由於缺乏鈣、磷、維他命D等礦物質,導致骨結構和骨質量異常。骨礦物質診斷檢驗診斷可用於骨疾病的治療的變化、評估。全球骨鹽診斷檢驗市場,預計2014∼2019年以年複合成長率4.33%擴大。

本報告提供全球骨礦物質診斷檢驗市場相關調查、該市場的現狀與至2019年的成長前景、各地區趨勢、主要供應商概要、市場課題與趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 償付與補償:概要

  • 目前方案:診斷檢驗的評估
  • 美國的報銷問題結構
  • EU的償付結構
  • 以償付政策為中心的課題

第7章 各用途市場市場區隔

  • 維他命D檢驗
  • 骨骼代謝

第8章 各技術市場區隔

  • ELISA
  • CLIA
  • 其他檢驗

第9章 各產品市場區隔

  • 化驗/消耗品
  • 設備

第10章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第11章 推動市場的要素

  • 骨疾病的發病率上升
  • 早期診斷和預防醫療
  • 高齡化

第12章 促進要素的影響

第13章 市場課題

第14章 促進要素與課題的影響

第15章 市場趨勢

  • 化驗自動化
  • 新興國家的成長
  • 對POC診斷檢驗的著重
  • 意識提升和政府及非營利團體所扮演的角色

第16章 供應商環境

  • 競爭模式
  • 2014年的市場佔有率分析
  • 其他值得注意的供應商

第17章 主要供應商分析

  • Abbott Diagnostics
  • BioMrieux
  • DiaSorin
  • Roche Diagnostics
  • Siemens Healthcare
  • Quidel

第18章 附錄

第19章 關於Technavio

圖表

目錄
Product Code: IRTNTR7584

About bone and mineral diagnostic testing

Bone and mineral disorders are caused by deficiency of minerals such as calcium, phosphorus, vitamin D, and abnormalities of bone structure or bone mass. Osteoporosis, Paget's disease, and osteogenesis imperfecta are some of the common bone diseases. Bone and mineral diagnostic tests are used for diagnosis and assessment of changes in response to bone disorder therapy. These tests are performed using technologies such as ELISA, CLIA, and RIA.

Technavio's analysts forecast the global bone and mineral diagnostic testing market to grow at a CAGR of 4.33% over the period 2014-2019.

Covered in this report

In this report, Technavio covers the present scenario and growth prospects of the global bone and mineral diagnostic testing market for the period 2015-2019. To calculate the market size, we use revenue generated from the sales of the following product application categories:

  • Vitamin D testing
  • Bone metabolism testing (osteocalcin, parathyroid hormone (PTH), and bone alkaline phosphatase (BAP) assays)

Technavio's report, Global Bone and Mineral Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas APAC, and EMEA; it also covers the landscape of the global bone and mineral diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Abbott Diagnostic
  • bioMrieux
  • Diasorin
  • Quidel
  • Roche Diagnostic
  • Siemens Healthcare

Other Prominent Vendors

  • Alere
  • ALPCO
  • Beckman Coulter
  • Biomedica Immunoassays
  • Bio-Rad Laboratories
  • Calbiotech
  • DIAsource ImmunoAssays
  • DRG INSTRUMENTS
  • Eagle BioSciences
  • Enzo Life Sciences
  • Epitope Diagnostics
  • IASON
  • IBL International
  • Immundiagnostik
  • Immunodiagnostic Systems
  • ORGENTEC Diagnostika
  • Orion Diagnostica
  • Ortho-Clinical Diagnostics
  • TECOmedical

Market driver

  • Increasing incidences of bone disorders
  • For a full, detailed list, view our report

Market challenge

  • Pricing erosion in established countries
  • For a full, detailed list, view our report

Market trend

  • Development in automation of assay
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Reimbursement and coverage: An overview

  • Current scenario: Validating diagnostic tests
  • Reimbursement structure in the US
  • Reimbursement structure in EU
  • Prevailing issues of reimbursement policies

PART 07: Market segmentation by application

  • Vitamin D testing
  • Bone metabolism

PART 08: Market segmentation by technology

  • ELISA
  • CLIA
  • Other tests

PART 09: Market segmentation by product

  • Assays/consumables
  • Instruments

PART 10: Geographical segmentation

  • Bone and mineral diagnostic testing market in Americas
  • Bone and mineral diagnostic testing market in EMEA
  • Bone and mineral diagnostic testing market in APAC

PART 11: Market drivers

  • Increasing incidence of bone disorders
  • Early diagnosis and preventive medicine
  • Increase in geriatric population

PART 12: Impact of drivers

PART 13: Market challenges

  • Pricing erosion in established countries
  • Limited detection capability and complexity
  • Reimbursement and regulatory hurdles

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Development in automation of assays
  • Growing focus on emerging countries
  • Focus on POC diagnostic tests
  • Increase in awareness and role of government and non-profit institutions

PART 16: Vendor landscape

  • Competitive scenario
  • Key vendor analysis 2014
  • Other prominent vendors

PART 17: Key vendor analysis

  • Abbott Diagnostics
  • bioMrieux
  • DiaSorin
  • Roche Diagnostics
  • Siemens Healthcare
  • Quidel

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global bone and mineral diagnostic testing market 20142019 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Reimbursement perspectives of healthcare entities
  • Exhibit 05: Global bone and mineral diagnostic testing market segmentation by application
  • Exhibit 06: Segmentation of global bone and mineral diagnostic testing market by application 2014
  • Exhibit 07: Global vitamin D diagnostic testing market 20142019 ($ millions)
  • Exhibit 08: Global bone metabolism diagnostic testing market 20142019 ($ millions)
  • Exhibit 09: Global bone and mineral diagnostic testing market by application 20142019
  • Exhibit 10: Global bone and mineral diagnostic testing market segmentation by technology
  • Exhibit 11: Segmentation of global bone and mineral diagnostic testing market by product 2014
  • Exhibit 12: Segmentation of global bone and mineral diagnostic testing market by geography 2014
  • Exhibit 13: Segmentation of global bone and mineral diagnostic testing market by geography 2019
  • Exhibit 14: Segmentation of global bone and mineral diagnostic testing market by geography 20142019
  • Exhibit 15: Bone and mineral diagnostic testing market in Americas 20142019 ($ millions)
  • Exhibit 16: Bone and mineral diagnostic testing market in EMEA 20142019 ($ millions)
  • Exhibit 17: Bone and mineral diagnostic testing market in APAC 20142019 ($ millions)
  • Exhibit 18: Impact of drivers
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Estimated healthcare spending in BRIC countries in 2015 ($ billions)
  • Exhibit 21: Key takeaways: Abbott Diagnostics
  • Exhibit 22: Key takeaways: bioMrieux
  • Exhibit 23: DiaSorin: Key takeaways
  • Exhibit 24: Roche Diagnostics: Key takeaways
  • Exhibit 25: Siemens Healthcare: Key takeaways
  • Exhibit 26: Quidel: Key takeaways
  • Exhibit 27: Abbott Diagnostics: Key business offerings
  • Exhibit 28: bioMrieux: Applications by technology
  • Exhibit 29: DiaSorin: Business segmentation by revenue 2014
  • Exhibit 30: DiaSorin: Business segmentation by revenue 2013 and 2014
  • Exhibit 31: DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 32: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 33: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 34: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 35: Siemens Healthcare: Business segmentation
  • Exhibit 36: Siemens Healthcare: Geographical segmentation by revenue 2014
  • Exhibit 37: Quidel: Product segmentation by revenue 2014
  • Exhibit 38: Quidel: Product segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 39: Quidel: Geographical segmentation by revenue 2014
Back to Top